Mary F. Azer

Birtinya, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trial.

Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trial.

Journal: BMJ open
Published: June 19, 2025

Drug-induced liver injury secondary to tamoxifen.

Drug-induced liver injury secondary to tamoxifen.

Journal: Drug and therapeutics bulletin
Published: February 13, 2025

Drug-induced liver injury secondary to tamoxifen.

Drug-induced liver injury secondary to tamoxifen.

Journal: BMJ case reports
Published: June 05, 2024

The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review.

The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review.

Journal: Pathology
Published: October 22, 2023

Management of basal cell carcinoma with pulmonary metastasis.

Management of basal cell carcinoma with pulmonary metastasis.

Journal: BMJ case reports
Published: January 04, 2023

Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis.

Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis.

Journal: Pigment cell & melanoma research
Published: April 11, 2022

Features and management of pyrexia with combined dabrafenib and trametinib in metastatic melanoma.

Features and management of pyrexia with combined dabrafenib and trametinib in metastatic melanoma.

Journal: Melanoma research
Published: July 24, 2014

The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibition.

The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibition.

Journal: Cancer
Published: January 19, 2014

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.

Journal: PloS one
Published: October 30, 2013

Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.

Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.

Journal: Cancer
Published: July 30, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026